Hepcinat LP 90/400 mg
Available Dosages
| SKU | 2165 |
|---|---|
| Generic For | Hepcinat |
| Strength | 90/400mg |
| Manufacturer | Natco Pharma |
| Active Ingredient | Ledipasvir 90mg & Sofosbuvir 400mg |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 28 Tablet/s | US$ 12.50 | US$ 350.00 | |||
|
|||||
| 56 Tablet/s | US$ 11.16 | US$ 625.00 | |||
|
|||||
Hepcinat LP 90/400 mg (Ledipasvir 90mg & Sofosbuvir 400mg)
Hepcinat LP 9/400 is a fixed-dose combination of Sofosbuvir and Ledipasvir which are approved for the treatment of people who are infected with hepatitis C genotype 1 and 4. The combination drug is clinically tested for treating HCV infection, which does not require ribavirin and interferon. Numerous research studies have revealed its extremely high success rate when it comes to treating chronic, long-lasting, a viral infection of the liver. Both the active ingredients work by reducing the amount of Hepatitis C virus from your body, boost the immune system to fight against the infection, and help your liver to recover. Natco Pharma manufactures this treatment option for the complete elimination of chronic hepatitis C virus. Doctors prescribe it to destroy the virus and preventing the replication of the virus.
Clinical uses of Hepcinat LP 9/400 mg
Hepcinat LP is one of the most effective treatments for hepatitis C. It is suitable for patients with hepatitis C genotype 1 and 4. It is also beneficial for people with cirrhosis of the liver caused by the hepatitis C virus. This medicine is a combination of two active ingredients, namely Ledipasvir and Sofosbuvir, that helps in reducing the amount of the virus in the body, by preventing the spread of the virus to other parts of the body. This combination drug is beneficial in treating chronic, a prolonged lasting viral infection of the liver. Sometimes the medicine may be used with another antiviral agent like ribavirin. Hepcinat LP 9/400 encourages the immune system to fight against the infection and may help your liver to recover. Chronic hepatitis C infection may cause scarring of the liver, and the condition can be called as liver cirrhosis.
Keep in mind that antacids lower the absorption of ledipasvir and Sofosbuvir, so it recommended to take it at least four hours before or after Hepcinat LP 90/400 mg. Acid-lowering medications such as indigestion ulcers, heartburn, and other, including famotidine, and omeprazole may delay the effects of your antiviral medicines. Ask your doctor to use these medications safely.
Dosing Instructions of Hepcinat LP 90/400 mg
Take Hepcinat LP before or after consuming food as per your doctor’s instructions. The fixed dose combination drug works best when the absorption of the drug takes place at a constant level, to make this happen, it is better to take this medicine at evenly spaced intervals. Let your doctor know if you vomit within five hours of taking the drug. You may be advised to take another dose. Continue to take the antiviral medication as per your doctor’s instructions. Do not stop taking it even if the symptoms disappear after a short time. Patients are instructed to complete the full course of treatment to avoid recurrence of the infection.
Possible Side Effects of Hepcinat LP 90/400 mg
Headache, diarrhea, nausea, or difficulty sleeping are the commonly reported side effects of Hepcinat LP If any of these cause trouble or persist for a longer duration, immediately talk to your doctor. Remember that your doctor has prescribed this antiviral agent because he/she has judged that the benefits are greater than the risk of adverse effects. There are other side effects as well that you can experience while using This medication. Contact your doctor for the complete list of drugs.
What is Ledipasvir 90mg & Sofosbuvir 400mg and what condition does it treat?
Ledipasvir 90mg & Sofosbuvir 400mg, marketed as Hepcinat LP 90/400 mg, is a fixed-dose combination antiviral medicine used to treat chronic hepatitis C virus (HCV) infection. This direct-acting antiviral therapy targets specific genotypes of the hepatitis C virus, helping patients achieve sustained virologic response. The combination tablet brings together two powerful antivirals that work synergistically to eliminate the virus from your body. This HCV treatment is prescribed for adults with chronic hepatitis C, including those with compensated cirrhosis, and has revolutionized hepatitis therapy by offering shorter treatment durations and higher cure rates compared to older interferon-based regimens.
How does Ledipasvir 90mg & Sofosbuvir 400mg work in the body?
Hepcinat LP 90/400 mg works through a dual-action mechanism targeting different stages of the hepatitis C virus lifecycle. Sofosbuvir 400mg acts as a nucleotide analogue inhibitor, blocking the NS5B polymerase enzyme that the virus needs to replicate its genetic material. Ledipasvir 90mg functions as an NS5A inhibitor, preventing viral replication and assembly. Together, these direct-acting antivirals create a powerful barrier that stops HCV from multiplying and spreading throughout the liver. This combination antiviral therapy allows your immune system to clear existing virus particles, leading to sustained virologic response and potentially curing chronic hepatitis C infection within 8 to 24 weeks of treatment.
How long does Hepcinat LP 90/400 mg take to work?
Hepcinat LP 90/400 mg begins working immediately after your first dose, with Ledipasvir and Sofosbuvir starting to inhibit hepatitis C virus replication within hours. However, achieving undetectable viral load levels typically takes several weeks of consistent daily treatment. Most patients see significant reductions in HCV RNA levels within the first four weeks. Complete treatment duration ranges from 8 to 24 weeks depending on your HCV genotype, previous treatment history, and presence of cirrhosis. Sustained virologic response, meaning the virus remains undetectable 12 weeks after finishing therapy, is the ultimate goal and indicates successful eradication of chronic hepatitis C infection.
When and how should I take Hepcinat LP 90/400 mg?
Take one Hepcinat LP 90/400 mg tablet once daily at the same time each day, with or without food. Swallow the tablet whole with water without crushing, chewing, or splitting it. Consistency in timing helps maintain steady levels of Ledipasvir 90mg & Sofosbuvir 400mg in your bloodstream for optimal antiviral effectiveness. If you miss a dose and it's within 18 hours of your usual time, take it immediately; if more than 18 hours have passed, skip it and resume your regular schedule. Never double up doses of this hepatitis C medication. Your doctor will determine your treatment duration based on HCV genotype and medical history.
Is Hepcinat LP 90/400 mg safe for long-term use?
Hepcinat LP 90/400 mg is designed for short-term therapeutic use, typically 8 to 24 weeks, rather than indefinite long-term treatment. This hepatitis C therapy is intended to cure the infection, after which you discontinue the medication. Clinical trials have established the safety profile of Ledipasvir and Sofosbuvir combination for these prescribed durations. The medicine is generally well-tolerated during treatment periods, with most side effects being mild to moderate. Once you achieve sustained virologic response and your hepatitis C is cured, continued antiviral therapy is unnecessary. Your healthcare provider will monitor your liver function and viral load throughout treatment to ensure the medication is working effectively and safely.
Can I take Hepcinat LP 90/400 mg with other medicines?
Hepcinat LP 90/400 mg can interact with various medications, so informing your doctor about all medicines, supplements, and herbal products you take is essential. Ledipasvir and Sofosbuvir may interact with certain heart medications like amiodarone, acid-reducing drugs, anticonvulsants, antimycobacterials like rifampin, herbal supplements such as St. John's Wort, and some HIV medications. These interactions can reduce the effectiveness of your hepatitis C treatment or increase side effect risks. Your pharmacist can review your complete medication list for potential drug interactions. Some medicines may need dosage adjustments or temporary discontinuation during your antiviral therapy. Always verify compatibility before starting any new medication while taking this HCV treatment.
How does Hepcinat LP 90/400 mg compare to similar medicines in its class?
Hepcinat LP 90/400 mg belongs to the direct-acting antiviral class and compares favorably with other hepatitis C treatments like Harvoni, Epclusa, and Mavyret. This Ledipasvir and Sofosbuvir combination specifically targets HCV genotypes 1, 4, 5, and 6 with high cure rates exceeding 95%. Compared to older interferon-based therapies, this modern antiviral offers shorter treatment duration, fewer side effects, and higher success rates. While medications like Epclusa cover all HCV genotypes, Hepcinat LP provides excellent efficacy for its indicated genotypes at competitive pricing. The once-daily single-tablet regimen offers convenience similar to other contemporary hepatitis C medications, making treatment adherence easier compared to multi-pill regimens.
Is the generic Ledipasvir 90mg & Sofosbuvir 400mg as effective as branded versions?
Generic Ledipasvir 90mg & Sofosbuvir 400mg, such as Hepcinat LP 90/400 mg, delivers equivalent therapeutic effectiveness to branded versions like Harvoni. Licensed generic manufacturers must demonstrate bioequivalence, meaning the generic antiviral produces the same clinical outcomes as the brand-name hepatitis C medication. The active pharmaceutical ingredients, dosage strength, and mechanism of action remain identical between generic and branded formulations. Clinical studies confirm generic direct-acting antivirals achieve comparable sustained virologic response rates in treating chronic HCV infection. The primary difference lies in pricing, with generic versions offering significant cost savings while maintaining quality standards. Many patients worldwide successfully achieve hepatitis C cure using affordable generic alternatives manufactured by reputable pharmaceutical companies.
Why do patients choose PremiumRxDrugs for Hepcinat LP 90/400 mg?
Patients select PremiumRxDrugs for Hepcinat LP 90/400 mg because of competitive pricing that makes this Ledipasvir and Sofosbuvir combination affordable without compromising quality. As a licensed international pharmacy trusted for over ten years, we guarantee authentic manufacturer-sourced hepatitis C medications delivered discreetly worldwide. Our service advantages include easy prescription management, straightforward reordering, and free shipping options that reduce treatment costs. Patients across the USA, UK, Australia, and Canada appreciate access to genuine generic and branded antiviral therapies at prices significantly lower than local pharmacies. The combination of pharmaceutical authenticity, global shipping reliability, competitive pricing, and established reputation makes PremiumRxDrugs a preferred source for affordable HCV treatment.
What are the common side effects of Ledipasvir 90mg & Sofosbuvir 400mg?
Common side effects of Ledipasvir 90mg & Sofosbuvir 400mg include fatigue, headache, nausea, and insomnia during hepatitis C treatment. Some patients experience weakness, irritability, or diarrhea while taking this antiviral combination. These effects are typically mild to moderate and often diminish as your body adjusts to the medication. Less common reactions may include dizziness, muscle aches, or decreased appetite. Most people tolerate this HCV therapy well and complete their full treatment course. Serious side effects are rare but can include severe slowing of heart rate when combined with certain cardiac medications, or reactivation of hepatitis B in co-infected individuals. Contact your healthcare provider if side effects become bothersome or you experience unusual symptoms.
Who should avoid taking Ledipasvir 90mg & Sofosbuvir 400mg?
Individuals with severe liver impairment beyond compensated cirrhosis should avoid Ledipasvir 90mg & Sofosbuvir 400mg without specialist guidance. Patients taking medications containing amiodarone face significant cardiac risks and require alternative hepatitis C treatments or careful monitoring. Those with known hypersensitivity to Ledipasvir, Sofosbuvir, or any tablet components should not use this antiviral therapy. Pregnant women should discuss risks and benefits, as data on this HCV medication during pregnancy remains limited. People with hepatitis B co-infection require close monitoring due to potential HBV reactivation risks. Anyone currently taking certain medications that significantly interact with this direct-acting antiviral combination may need treatment alternatives. Always disclose your complete medical history before starting hepatitis C therapy.
Login
Sign Up
Login
Sign Up